Departures from cost-effectiveness recommendations: The impact of health system constraints on priority setting

Health Systems and Reform

Volumn 2, Issue 1, 2016, Pages 61-70

  Hauck, Katharina ^a   Thomas, Ranjeeta ^a   Smith, Peter C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cost effectiveness analysis; Decision making; Health technology assessment; Implementation; Priority setting

Indexed keywords

EID: 85003235741     PISSN: 23288604     EISSN: 23288620     Source Type: Journal    
DOI: 10.1080/23288604.2015.1124170     Document Type: Article

References (39)

1. Drummond M, Sculpher M, Torrance B, O’Brien BJ, Stod-dart G. Methods for the economic evaluation of health care programmes (3rd ed.). Oxford: Oxford University Press; 2005.
2. World Health Organization. Health intervention and technology assessment in support of universal health coverage: World Health Assembly Resolution 67.23. Geneva: World Health Organization; 2014.
3. Tarn T, Smith MD. Pharmacoeconomic guidelines around the world. ISPOR Connections 2004; 10(4): 5-15.
4. Smith PC. Incorporating financial protection into decision rules for publicly financed healthcare treatments. Health Econ 2013; 22(2): 180-193.
5. Atun RA, Bennett S, Duran A. When do vertical (stand-alone) programmes have a place in health systems? Geneva: World Health Organization; 2008.
6. World Health Organization. Paying for performance in health care: implications for health system performance and accountability, Health Division Department of Employment, Labour and Social Affairs, ed. Paris: OECD Publishing; 2014.
7. Oliveira-Cruz V, Hanson K, Mills A. Approaches to overcoming constraints to effective health service delivery: a review of the evidence. J Int Dev 2003; 15(1): 41-65.
8. Stinnett AA, Paltiel AD. Mathematical programming for the efficient allocation of health care resources. J Health Econ 1996; 15(5): 641-653.
9. Adang EM. Economic evaluation of innovative technologies in health care should include a short-run perspective. Eur J Health Econ 2008; 9(4): 381-384.
10. Fenwick E, Claxton K, Sculpher M. The value of implementation and the value of information: combined and uneven development. Med Decis Making 2008; 28(1): 21-32.
11. Dixon J, Welch HG. Priority setting: lessons from Oregon. Lancet 1991; 337(8746): 891-894.
12. Mitton C, Donaldson C. Twenty-five years of programme budgeting and marginal analysis in the health sector, 1974– 1999. J Health Serv Res Policy 2001;6(4): 239-248.
13. Airoldi M, Morton A, Smith JAE, Bevan G. STAR—people-powered prioritization: a 21st-century solution to allocation headaches. Med Decis Making 2014; 34(8): 965-975.
14. World Health Organization. Generalized cost-effectiveness analysis. Geneva: World Health Organization; 2015. Available at http://www.who.int/choice/cost-effectiveness/gen eralized/en/ (accessed 25 November 2015)
15. O’Brien BJ, Sculpher MJ. Building uncertainty into cost-effectiveness rankings—portfolio risk–return tradeoffs and implications for decision rules. Med Care 2000; 38(5): 460-468.
16. Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 1997; 16(1): 33-64.
17. Fenwick E, O’Brien BJ, Briggs A. Cost effectiveness acceptability curves—facts, fallacies and frequently asked questions. Health Econ 2004; 13(5): 405-415.
18. Griffin SC, Claxton K. Analyzing uncertainty in cost-effectiveness for decision-making. In: The Oxford handbook of health economics, Glied S, Smith PC, eds. Oxford: Oxford University Press; 2011; 759-787.
19. Revill P, Woods B, Sculpher M. Economic evaluation of healthcare programs and interventions: applications to low-and middle-income countries. In: World scientific handbook of global health economics and public policy, Scheffler RM, ed. Hackensack, NJ: World Scientific Publishing Co Pte Ltd; 2015; 114-123.
20. Claxton K, Sculpher M, Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet 2002; 360(9334): 711-715.
21. Spiegelhalter DJ, Best NG. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Stat Med 2003; 22(23): 3687-3709.
22. Bojke L, Claxton K, Sculpher M, Palmer S. Characterizing structural uncertainty in decision analytic models: a review and application of methods. Value Health. 2009; 12(5): 739-749.
23. Jackson CH, Thompson SG, Sharples LD. Accounting for uncertainty in health economic decision models by using model averaging. J R Stat Soc Ser A Stat Soc 2009; 172(2): 383-404.
24. Claxton K, Sculpher M. Using value of information analysis to prioritise health research. Pharmacoeconomics 2006; 24(11): 1055-1068.
25. Rosenhead J. Planning under uncertainty: II. A methodology for robustness analysis. J Oper Res Soc 1980; 31(4): 331-341.
26. Palmer S, Smith PC. Incorporating option values into the economic evaluation of health care technologies. J Health Econ 2000; 19(5): 755-766.
27. Smith PC, Anell A, Busse R, Crivelli L, Healy J, Lindahl AK, Westert G, Kene T. Leadership and governance in seven developed health systems. Health Policy 2012; 106 (1): 37-49.
28. Smith PC, Mossialos E, Papanicolas I. Performance measurement for health system improvement: experiences, challenges and prospects. New York: Cambridge University Press; 2009.
29. Glassman A, Chalkidou K. Priority-setting in health: building institutions for smarter public spending. Washington, DC: Center for Global Development; 2012.
30. Hauck K, Smith PC. The politics of priority setting for health: a political economy perspective. Washington, DC: Center for Global Development; 2015.
31. Goddard M, Hauck K, Preker A, Smith PC. Priority setting in health—a political economy perspective. Health Econ Policy Law 2006; 1(1): 79-90.
32. Ahmed S, Greene K. Is the median voter a clear-cut winner?: comparing the median voter theory and competing theories in explaining local government spending. Public Choice 2000; 105(3–4): 207-230.
33. Olson M. The logic of collective action: public goods and the theory ofgroups(reviseded.). Cambridge: HarvardUniversityPress; 1971.
34. Tullock G. The politics of bureaucracy. Washington, DC: Public Affairs Press; 1965.
35. Niskanen WA. Bureaucracy and representative government. Chicago: Aldine-Atherton; 1971.
36. Tuohy CH, Glied S. The political economy of health care. In: The Oxford handbook of health economics, Glied S, Smith P, eds. Oxford: Oxford University Press; 2011; 58-77.
37. Asaria M, Griffin S, Cookson R, Whyte S, Tappenden P. Distributional cost-effectiveness analysis of health care programmes-a methodological case study of the UK Bowel Cancer Screening Programme. Health Economics 2015; 24(6): 742-754.
38. Mitton C, Smith N, Peacock S, Evoy B, Abelson J. Public participation in health care priority setting: a scoping review. Health Policy 2009; 91(3): 219-228.
39. Dolan P, Peasgood T, White M. Do we really know what makes us happy? A review of the economic literature on the factors associated with subjective well-being. Journal of Economic Psychology 2008; 29(1):94-122.